Structural Formula (Fam0b 0000 01)
Famotidine Injection, Solution
Product Images NDC 25021-754
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Famotidine (NDC 25021-754). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Sagent Pharmaceuticals, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Package Label – Principal Display Panel – Vial Label (Fam0b 0000 02)
Description: This is a Famotidine Injection, USP with the NDC number 25021-753-02. Manufactured for SAGENT Pharmaceuticals in Schaumburg, IL, USA, and made in India. The product comes in a 2 mL Single-Dose Vial with a specific code number. Dosage instructions and other details are provided on the package insert.*
Package Label – Principal Display Panel – Vial Label (Fam0b 0000 03)
Package Label – Principal Display Panel – Vial Label (Fam0b 0000 04)
This text contains information about a pharmaceutical product, specifically Famotidine Injection, USP with 200 mg per 20 1+ (10 mg per mL) concentration, manufactured for SAGENT Pharmaceuticals in Schaumburg, IL, USA, with the code TN/DRUGS/616/1996. It also mentions that the product is made in India. The NDC for this product is 25021-754-20.*
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
